Press Releases and Announcements
March 31, 2021Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
Martin Kessler will drive company-wide transformation and lead the ongoing expansion at the U.S. site
Highly successful strategic alliance for biopharmaceutical development and formulation
March 11, 2021New Modalities and Biopharma Partnerships
Our Experts featured in the European Biotechnology Spring Edition.
Rentschler Biopharma was honored by the CMO Leadership Awards 2021 in the core categories of Reliability and Compatibility.
February 10, 2021Rentschler Biopharma entry into cell and gene therapy
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK
February 10, 2021Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansion
Rentschler Biopharma responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany
December 15, 2020Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing
CEO Frank Mathias’ cover feature in Pharma’s Almanac
December 1, 2020Diana Wiedmann, new Senior Vice President Human Relations, responsible for global strategic development of human relations
Highly qualified team of three are taking the lead at Rentschler Biopharma’s HR department
Targeted therapy, smart devices and patient support programs ensure patient well-being and benefit society at large
October 27, 2020Rentschler Biopharma and INFOMOTION develop cloud-based datacenter for flexible and highly secure access to product information
An Interview by Wolfram Schulze about digital client benefits
October 22, 2020Benefits of combining bioinformatics and an algorithm- and database-driven approach for biopharmaceutical stabilization
Article on how we maximize API potential for clients via our strategic alliance with Leukocare
October 19, 2020Entrepreneurial success driven by vision and freedom
An Interview about Rentschler Biopharma’s history and future
Technology will be integrated into Rentschler Biopharma’s in-house process with a fast, cost-effective, and stable platform to complement existing CLD offering
October 7, 2020Joining forces against SARS-CoV-2
Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine
October 1, 2020Sustainable value creation and a spirit of innovation
CEO Frank Mathias featured in in this year’s Biotechnology issue of Plattform Life Sciences.
September 30, 2020Collaboration and continuous optimization: Cornerstones of our strategy
Article on our strategic collaboration with Vetter Pharma and insights on our COVID-19 response in Pharma’s Almanac latest issue
Detailed capabilities review published in the latest BPI Industry Innovators Issue
July 20, 2020Competitive advantages of a family-owned business
Flexible decision-making leads to sustainable value creation
July 16, 2020Rentschler Biopharma’s expansion plans at U.S. site driven by an innovative business model
Interview with Federico Pollano, SVP Global BD
Rentschler Biopharma and Vetter team up with joint goal to simplify processes and optimize time-to-market
July 1, 2020Medical Biotechnology in Germany 2020
The German biotech landscape holds immense potential for advanced therapy medicinal products.
Alexander Dettmer will head the finance, supply chain management, legal and information technology functions
Innovative agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in development
May 25, 2020United we are stronger
Cooperation in times of COVID-19 is key to weathering the crisis
May 19, 2020Rentschler Biopharma extends its cell line development (CLD) solutions for difficult-to-express proteins
Horizon Discovery’s CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house process
May 18, 2020The Smart Workplace at Rentschler Biopharma
What are the key elements defining smart workplaces at a biopharma CDMO?
April 27, 2020Rentschler Biopharma’s COVID-19 Response
Reliable delivery of essential therapeutics is our top priority
CEO Frank Mathias’ article on Strategy 2025
Pharmind article about the Industry survey that predicts increasing investment in formulation development
Interview with Matthias Walter in the “Best in Procurement” Magazine
February 18, 2020“CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary
The futuristic facility will focus on process innovation and the production of designer biologics
February 18, 2020Outsourcing Services: from Gene to Patient
CEO Frank Mathias in ChemManager Interview
February 13, 2020Rentschler Biopharma Adds Senior Executive to Growing U.S. Team
Grace Kim joins as Vice President Business Development – North America and APAC
New 500 L bioreactor in operation mid-2020 at U.S. site
Company’s clinical and commercial manufacturing capabilities to be showcased during BIO-Europe, November 11-13 in Hamburg, Germany
Rentschler Biopharma management duo received the award on October 25
October 10, 2019Rentschler Biopharma Announces Appointment of Karen Savage to Milford Area Chamber of Commerce Board of Directors
Vice President Milford Karen Savage joins the Board of the Milford Area Chamber of Commerce
Rentschler Biopharma for the second year in a row ranks among the best employers in the biotechnology sector by "Germany's most attractive employer" of the F.A.Z.-Institute.
October 4, 2019Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base
Company also announces participation in BioJapan 2019, one of Asia’s largest partnering events for the global biotechnology industry, October 9-11, 2019 in Pacifico Yokohama
September 18, 2019Rentschler Biopharma is finalist for "EY Entrepreneur of the Year 2019"
Rentschler is among the 38 companies that have made it to the final round of the coveted Entrepreneur Award
September 4, 2019Rentschler Biopharma to highlight new U.S. facility and bioprocessing expertise at Biotech Week Boston
Major presence at BioProcess International (BPI) Conference, September 9-12 during Biotech Week Boston. Focus on Company’s manufacturing and process development innovations with potential to significantly improve timelines and efficiency
Germany is “the place to be” for innovative solutions and research services in the medical biotechnology field.
Biopharmaceuticals set a new record: there were 38 approvals in 2018, as many as in the previous two years combined.
June 13, 2019Making Downstream Processing Continuous and Robust
Scientists of Rentschler Biopharma participated in a virtual roundtable for the Bioprocess International magazine
Die Rentschler Biopharma SE sets foot in the U.S.
New Article published by our SVP Business Development Federico Pollano
March 31, 2019Early stage development of avanced formulations in the drug development process provides competitive advantages
Survey "Formulation in the Drug Product Development Process" predicts that drug product formulation recognition and budgets will increase significantly.
March 13, 2019Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position
An article written by our SVP Business Development Federico Pollano for the Q1 issue of pharma’s almanac
February 28, 2019Article on smart medicine published in Plattform Life Sciences
"Chances of digitalization" by Wolfram Schulze and Tobias Rother
January 29, 2019Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management
Rentschler Biopharma SE announced today the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.
Rentschler Biopharma SE announced that the Company has completed the acquisition of a manufacturing facility from an affiliate of Shire plc.
December 20, 2018Rentschler Biopharma SE appoints Henning Gerschewski as Vice President Manufacturing Science and Technology
Rentschler Biopharma SE announced that Henning Gerschewski will join the company as Vice President Manufacturing Science and Technology, effective January 01, 2019.
Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc
December 13, 2018Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation
Rentschler Biopharma SE announced that Dr. Jesús Zurdo will join the company as SVP Process Science and Innovation, effective January 01, 2019.
November 6, 2018Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly
Rentschler Biopharma SE and LEUKOCARE AG reported results from their joint publication of the 2018 Survey ‘Formulation in the Drug Product Development Process’, based on research from Informa Pharma Intelligence.
October 24, 2018Interview with Michael Scholl of Leukocare
October 18, 2018Rentschler Biopharma and LEUKOCARE to announce findings of international Drug Product Formulation Survey at BIO-Europe 2018
The survey provides latest insights into the status quo and future of drug product formulation and its potential to refine all steps in the biopharmaceutical value chain.
The 5th Laupheim Biotech Days, a bi-annual, two-day event organized by Rentschler Biopharma, took place in Laupheim, Germany on September 20th and 21st, 2018.
September 14, 20182017 was another record year for medical biotechnology in Germany
The latest biotech report from vfa bio and the Boston Consulting Group on the state of medical biotechnology in Germany is now available
September 10, 2018Interview with Dr. Frank Mathias, CEO, Dr. Ralf Otto, COO, and Federico Pollano, SVP Business Development, in European Business Magazine
From gene to vial and from clinic to market
August 31, 2018Interview with our Federico Pollano
Combining established and novel technologies
Quality from Upper Swabia - claiming technology leadership in the pharmaceutical business
June 28, 2018Article in European Biotechnology Magazine Summer 2018 „Combining established and novel technologies”
An interview with Federico Pollano, SVP Business Development
“Biopharma CDMO success requires technical leadership and problem-solving capabilities”
by Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE
June 1, 2018Article in Journal of Biotechnology, May 2, 2018
“Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification”
by Anja Trapp, Alexander Faude, Natalie Hörold, Sven Schubert, Sabine Faust, Thilo Grob, Stefan Schmidt
May 18, 2018Customer focus as a growth strategy
Interview with Federico Pollano in the special issue of the transkript to BIO 2018
May 11, 2018How Rentschler Biopharma is facing the future
Presentation of Rentschler Biopharma's "Strategy 2025" at the Swiss Biotech Day 2018
With a record attendance of more than 1000 participants, the 9th German Biotechnology Days took place in Berlin on April, 18th and 19th 2018.
April 25, 2018Rentschler Biopharma is preparing for the future
Rentschler Biopharma's CEO is presenting at the Swiss Biotech Day 2018
Focus on Biotech in Germany
April 5, 2018Impressions from the BIO-Europe Spring in Amsterdam
Together with our strategic partners Leukocare AG and Rentschler Fill Solutions, we are looking back on very successful days at BIO-Europe Spring from March 12 to 14, 2018 in Amsterdam.
“Modular approaches for diverse molecules: reinventing smart bioprocessing”
March 28, 2018Rentschler Biopharma SE hires Dr. Thomas Rösch as Vice President Biopharma Engineering & Technology
Rentschler Biopharma SE announced that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
March 26, 2018Publication in Pharm. Ind. 80, No. 2 (2018)
“Biopharmaceutical manufacturing in single-use bioreactors” by Tina Lütke-Eversloh and Peter Rogge
March 16, 2018Join Rentschler Biopharma at the BPI West 2018
We kindly invite you to meet us at this year’s BioProcess International West conference in San Francisco, CA from March, 19th to 22nd 2018.
March 15, 2018A streamlined mAb platform process will be presented at the Bioprocessing Summit Europe 2018
Integration of single-use adsorptive filtration as a unit operation for virus clearance
March 13, 2018“Transkript persönlich” presents Dr. Ralf Otto
In the March issue of the German magazine Transkript, Dr. Ralf Otto, the new COO of Rentschler Biopharma SE, gives a short insight into his life in- and outside of his office.
March 9, 2018Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation
First year of alliance delivers project wins – including four with US-based clients – proving effectiveness of new strategy
We warmly invite you to meet us at the BIO-Europe Spring in the RAI Convention Center in Amsterdam from the 12th to 14th of March.
February 28, 2018Rentschler Biopharma SE appoints Federico Pollano as Senior Vice President, Business Development
Rentschler Biopharma SE announced that Federico Pollano has joined the Company as Senior Vice President, Business Development, effective March 1, 2018.
January 31, 2018Rentschler Biopharma SE appoints international biopharma expert Dr. Ralf Otto as Chief Operating Officer
Rentschler Biopharma SE appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.
January 29, 2018Presentation about design, structure, and manufacturability of fusion proteins at PepTalk 2018
Improved manufacturability of designed proteins
January 18, 2018Article in Laborwelt 2017
“Expensive affinity purification”
January 3, 2018Presentation about smart bioprocessing strategies for fusion proteins at PepTalk 2018 in San Diego, CA
“Design, structure and manufacturability: Lessons learned from fusion proteins”
Caprylic acid-induced precipitation as beneficial tool for mAb purification design
November 29, 2017Article in Bioprocess International Vol 15, Issue 10, November 2017
"Antibody–Drug Conjugates: Fast-Track Development from Gene to Product"
November 13, 2017Rentschler Biopharma and its partners collectively presented themselves at BIO-Europe
Full-service at the highest quality level
November 7, 2017Article in American Pharmaceutical Review October 2017
"Strategies to Predict the Developability of Biopharmaceuticals"
November 3, 2017Rentschler Biopharma will present at the PEGS Europe Summit 2017
Presenting a novel approach for antibody purification
World-class biomanufacturing solutions and delicious fruit juices
October 20, 2017Great interest in CDMO Services at the BioJapan 2017
Successful conversations and speedy portraits at the Rentschler Biopharma booth
October 17, 2017Article in European Biotechnology, Autumn 2017
"Advanced formulations for biopharmaceuticals"
October 16, 2017Article in Bioprocess International Vol 15, Issue 8, Featured Report, September 2017
“Controlling Glycosylation in Fusion Protein Manufacturing to Generate Potent Biobetters”
October 6, 2017Participation at two European Biotech events
Next-generation technologies and products
October 4, 2017Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE
Rentschler Biotechnologie GmbH has successfully transitioned into a European corporation (SE) on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect.
October 2, 2017Meet Rentschler Biopharma at BioJapan 2017
Receive a personal portrait by our caricaturist
September 14, 2017Invitation to meet Rentschler at BioProcess International 2017
Rentschler is pleased to announce its participation in the BioProcess International Conference and Exhibition, taking place from September 25 - 28, 2017 at the Hynes Convention Center in Boston, MA.
September 6, 2017CDMOs are champions for customization of single-use equipment
Inspiring presentation at The Bioprocessing Summit in Boston, MA
September 4, 2017Scientific Formulation Seminar & Workshop at the IZB in Martinsried
Advantages of the strategic alliance of Rentschler and Leukocare will be presented
August 18, 2017Presenting experience with single-use systems at the BioProcessing Summit in Boston, MA
Lecture on “Disposables in bioprocessing: Catalogue or customization?”
In the beginning of August, Rentschler hosted a meeting with Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Housing of Baden-Württemberg
August 7, 2017Rentschler is growing continuously
Growth is driven by the international market
Presentation about single-use trends in development and manufacturing
Rentschler presented itself at the BIO International Convention 2017
June 13, 2017Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities
Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH announced a strategic partnership
Invitation to visit the Rentschler booth No 1929
From May 14 to 17, 2017 more than 1,000 participants met for the 25th meeting of the European Society for Animal Cell Technology (ESACT) in Lausanne, Switzerland
The 25th Meeting of the European Society for Animal Cell Technology (ESACT) will be held from 14th to 17th May 2017 in Swisstech Convention Center, Lausanne, Switzerland
Presentation on fusion protein approaches to generate biobetter drugs
Exhibition booth at BIO-Europe Spring in Barcelona, Spain
March 27, 2017Article in European Biopharmaceutical Review April 2017
“Seize the Market”
“Drivers, Opportunities, and Limits of Continuous Processing”
Invitation to visit the Rentschler booth No 55.
Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance.
"Single-Use Depth Filters - Application in Clarifying Industrial Cell Cultures"
“Production Challenges for Complex Biologics: Fusion Proteins”
January 16, 2017Rentschler well-represented at PepTalk 2017
Expertise in innovative protein formats highlighted in three presentations
Rentschler joined the leading European biotech business conference
November 10, 2016Rentschler attended the largest European protein and antibody engineering conference
Presentation at the PEGS Europe
November 4, 2016Rentschler expands cGMP manufacturing capacity following increased international demand
Second 2,000 liter single-use bioreactor put into operation. Further capacity expansion only a few weeks after putting into operation an innovative Twin system.
November 2, 2016Participation at the Bio-Europe in Cologne, Germany
Invitation to visit the Rentschler booth No 11/12
October 20, 2016Article in World Pharma, Vol. 2, 2016
"A proud history of progress through biotechnology"
September 16, 2016Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals
Innovative Twin system with two 3,000 liter bioreactors and associated downstream processing equipment put into operation. Second significant expansion in one year.
September 15, 2016Rentschler Media Day
Rentschler has invited to a Media Day at Laupheim
"The Benefits and Limits of Disposable Technologies In Manufacturing Protein Therapeutics"
A pioneer in biotechnology
Press Event of IZB and BioM at Martinsried near Munich
Participation at the “Recovery XVII” in June
Artist at the booth attracted many visitors
June 17, 2016Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days
Topic: Fusion Proteins - delivering novel therapeutic options
Invitation to visit the Rentschler booth #923
Rentschler’s Turbocell™ platform and single-use vs. stainless steel decision process
February 17, 2016Participation in 15th Annual PepTalk Protein Science Week 2016
Presentation regarding the cost constraints in therapeutic protein manufacturing
February 15, 2016Rentschler appoints new CFO
Rentschler appoints Stefan Rampf to the position of CFO
January 29, 2016Article in BioProcess International, Supplement Dec 2015
"The Single-Use or Stainless Steel Decision Process"
January 7, 2016Rentschler appoints new Chief Executive Officer
Dr. Frank Mathias to become CEO of Rentschler Biotechnologie
December 15, 2015Rentschler announces 4th Laupheim Biotech Days
The biennial scientific conference is taking place from June 13 to 14, 2016
November 30, 2015Participation in PEGS Europe 2015
Rentschler presented at one the most important protein therapeutics development and manufacturing meetings in Europe
October 7, 2015Probiodrug and Rentschler sign manufacturing agreement
Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06
October 2, 2015Article in the European Biotechnology, Autumn Edition 2015
"Value-adding perfusion-based biomanufacturing"
Rentschler presented expertise with process platforms and modular configured processes to express and purify therapeutic Proteins
August 12, 2015Rentschler is responsible for providing cGMP drug substance of DX-2930 for Dyax Corp.
Client News: Dyax Corp. announced today
Dyax Corp. Provides Update on DX-2930 Clinical and Commercial Supply Initiatives
June 22, 2015Participation in PEGS Summit 2015
Rentschler presented at the essential protein engineering summit in Boston
April 14, 2015Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies
Rentschler expands manufacturing capabilities
March 23, 2015Rentschler commissions new 2,000L single-use bioreactor
Total single-use production capacity doubled
March 2, 2015Article in BioProcess International, Feb 2015
"Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal"
January 8, 2015Article in European Biotechnology Winter Edition 2014
"Increasing manufacturability with a modular approach"
November 26, 2014Article in Manufacturing Chemist, Oct 2014
"Employing new single-use technology in bioprocesses"
October 16, 2014Article in European Biotechnology, Autumn Edition 2014
"Taking mAb purification to the next level"
Highlights of the latest conference in Boston
July 16, 2014Article in transkript, Jul/Aug 2014
"Single-Use-Bioprocesses - Hype or Future-Technology?"
Rentschler announces the building of a Twin system with two 3,000 Liter stainless steel bioreactors mainly targeting market supply
2,000 L single-use bioreactor is planned to be in operation by the beginning of 2015.
Top-class exchange of experiences on the topics “Glycoengineering - Better Cells for Better Products” and “Challenges with Single Use Equipment”
May 27, 2014Article in BioProcess International, Apr 2014
"High-Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration"
Rentschler presentations at conferences in London and Boston
April 15, 2014Guest lectures at colleges and universities
Rentschler promotes the education of the next generation
Participation in international conferences and presentations of experiences and results from technology development and production.
March 14, 2014Rentschler announces 3. Laupheimer Zelltage
“Processes for Virus-based Biologics” is the focus of this year´s 3. Laupheimer Zelltage, which will be held from June 2-3.
March 10, 2014Article in transkript, Mar 2014
Platform technology and individual process, time-saving and cost-effective tachniques are required